ANI Pharmaceuticals Inc. (ANIP)
NASDAQ: ANIP
· Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
ANI Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 747.4M | 674.07M | 614.38M | 555.46M | 538.95M | 517.46M | 486.82M | 449.39M | 401.39M | 358.69M | 316.38M | 283.08M | 251.32M | 226.09M | 216.14M | 212.46M | 213.38M | 213.22M |
Cost of Revenue | 314.29M | 288.79M | 279.59M | 267.93M | 252.95M | 222.84M | 196.71M | 164.42M | 149.21M | 142.22M | 138.78M | 136.36M | 127.88M | 114.9M | 100.61M | 91.25M | 86.96M | 85.34M |
Gross Profit | 433.11M | 385.28M | 334.78M | 287.53M | 286M | 294.62M | 290.11M | 284.98M | 252.17M | 216.47M | 177.6M | 146.72M | 123.45M | 111.2M | 115.53M | 121.21M | 126.42M | 127.88M |
Operating Income | 15.19M | 6.47M | -4.67M | 6.43M | 44.9M | 52.13M | 46.97M | 42.06M | 23.18M | 212K | -28.88M | -54.42M | -57.04M | -62.03M | -39.79M | -15.74M | -9.38M | -5.13M |
Interest Income | 5.41M | 2.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -14.75M | -27.56M | -22.21M | -7.5M | 35.51M | 43.04M | 19.87M | 13.2M | -10.54M | -34.6M | -62.66M | -87.79M | -82.7M | -82.03M | -56.06M | -27.59M | -20.39M | -16.02M |
Net Income | -11.03M | -21.05M | -18.52M | -7.09M | 27.02M | 35.55M | 18.78M | 13.38M | -5.16M | -26.33M | -47.9M | -67.79M | -63.64M | -62.82M | -42.61M | -22.11M | -17.24M | -15.47M |
Selling & General & Admin | 307.09M | 278.14M | 249.64M | 224.38M | 187.31M | 173.25M | 161.7M | 150.42M | 138.5M | 131.69M | 124.04M | 121.56M | 108.66M | 95.52M | 84.29M | 67.95M | 66.5M | 68.89M |
Research & Development | 53.87M | 44.63M | 44.58M | 37.8M | 38.8M | 38.87M | 34.29M | 29.64M | 26.18M | 22.97M | 22.32M | 20.24M | 15.04M | 13.68M | 11.37M | 11.91M | 12.39M | 12.63M |
Other Expenses | 55.68M | 55.68M | 44.88M | 16.57M | 12.65M | 12.6M | 27.3M | 44.98M | 46.49M | 60.31M | 45.52M | 25.15M | 9.91M | -3.92M | -4.34M | -1.81M | -970K | -1.02M |
Operating Expenses | 416.64M | 378.46M | 339.1M | 278.75M | 238.76M | 239.47M | 238.03M | 239.78M | 225.91M | 214.97M | 206.53M | 197.97M | 177.28M | 160.85M | 143.69M | 128.1M | 126.95M | 132.57M |
Interest Expense | 24.67M | 21.11M | 17.6M | 17.33M | 21.4M | 23.84M | 26.94M | 28.7M | 29.57M | 29.14M | 28.05M | 24.99M | 20.22M | 16.08M | 11.92M | 10.04M | 10.05M | 9.87M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 682K | 682K | 682K |
Cost & Expenses | 730.93M | 667.24M | 618.69M | 548.67M | 493.7M | 464.29M | 436.72M | 404.2M | 375.12M | 357.19M | 345.31M | 334.33M | 305.15M | 275.75M | 244.31M | 219.35M | 213.91M | 217.91M |
Income Tax Expense | -4.54M | -6.51M | -3.69M | -412K | 8.49M | 7.5M | 1.09M | -184K | -5.38M | -8.28M | -14.77M | -20M | -19.06M | -19.21M | -13.46M | -5.49M | -3.17M | -571K |
Shares Outstanding (Basic) | 19.83M | 19.61M | 19.45M | 19.4M | 19.32M | 19.1M | 19M | 18.88M | 17.69M | 16.39M | 16.32M | 16.3M | 16.27M | 16.14M | 14.17M | 12.02M | 12.06M | 12M |
Shares Outstanding (Diluted) | 20.31M | 20.05M | 19.45M | 19.4M | 19.32M | 19.42M | 19.22M | 19.13M | 17.86M | 16.53M | 16.32M | 16.3M | 16.27M | 16.14M | 14.19M | 12.11M | 12.09M | 12.02M |
EPS (Basic) | -0.75 | -1.26 | -1.12 | -0.53 | 1.24 | 1.71 | 0.93 | 0.61 | -0.42 | -1.67 | -2.98 | -4.4 | -4.24 | -4.49 | -3.23 | -1.83 | -1.42 | -1.28 |
EPS (Diluted) | -0.77 | -1.27 | -1.13 | -0.54 | 1.23 | 1.70 | 0.93 | 0.61 | -0.42 | -1.67 | -2.98 | -4.4 | -4.24 | -4.49 | -3.23 | -1.83 | -1.42 | -1.28 |
EBITDA | 94.45M | 76.14M | 54.9M | 63.95M | 107.97M | 110.75M | 107.69M | 101.14M | 80.53M | 55.05M | 22.64M | -8.54M | -10.75M | -17.27M | 687K | 32.69M | 39.07M | 43.34M |
EBIT | 9.93M | -6.45M | -19.49M | -4.45M | 43.23M | 52.61M | 47.41M | 41.9M | 18.43M | -5.47M | -34.61M | -63.9M | -63.58M | -67.05M | -45.24M | -17.55M | -10.35M | -7.15M |
Depreciation & Amortization | 84.52M | 75.94M | 67.73M | 60.33M | 59.78M | 59.84M | 59.85M | 60.23M | 60.37M | 59.8M | 59.65M | 57.77M | 53.76M | 50.91M | 47.25M | 44.47M | 44.48M | 44.35M |